It has been proposed that enhanced levels of MUC1 expression by cancer cells may mask extracellular domains from immune surveillance, confer a survival advantage on malignant cells and play an important role in the ability of tumours to invade and metastasise (Mommers et al, 1999; Hughes et al, 2000b). The gene discussed is MUC1; the disease is neoplasm.